MYGN

MYRIAD GENETICS INC

Healthcare | Small Cap

-$0.25

EPS Forecast

$188.2

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.25

Revenue Forecast:

$188.2

EPS Surprise Forecast:

-$0.001

Revenue Surprise Forecast:

-$0

Post-release price volatility - Very high

Post-release Overnight Move:

±12.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

50%

Probability of beating revenue consensus:

48%

Probability of beating both EPS & revs consensus:

30%

Probability of missing both EPS & revs consensus:

31%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.73

Earnings volatility

EPS standard deviation:

$0.10

Revenue standard deviation:

$13

As % of share price:

2.47% VERY HIGH

As % of market cap:

3.17% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.12

Revenue 95th %ile:

$203

EPS 75th %ile:

-$0.21

Revenue 75th %ile:

$192

EPS 25th %ile:

-$0.28

Revenue 25th %ile:

$185

EPS 5th %ile:

-$0.38

Revenue 5th %ile:

$175

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

36% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

28% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$50

Bid-ask per Share:

$0.02